Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MO › SAINT LOUIS › R.J. TECHNOLOGY INC.

R.J. TECHNOLOGY INC.

NPI: 1003920349 · SAINT LOUIS, MO 63109 · Clinical Medical Laboratory · NPI assigned 08/17/2006

$1.63M
Total Medicaid Paid
103,628
Total Claims
94,704
Beneficiaries
83
Codes Billed
2018-01
First Month
2020-01
Last Month

Provider Details

Authorized OfficialRAZIQ, ABDUL (OWNER)
NPI Enumeration Date08/17/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 51,723 $776K
2019 48,899 $809K
2020 3,006 $46K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,853 3,384 $561K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,742 2,903 $160K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,271 1,840 $142K
84443 Thyroid stimulating hormone (TSH) 7,202 6,662 $97K
80053 Comprehensive metabolic panel 10,224 9,377 $86K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3,768 3,486 $69K
80061 Lipid panel 8,125 7,534 $69K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,146 1,043 $53K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9,858 8,883 $53K
83036 Hemoglobin; glycosylated (A1C) 5,355 4,955 $33K
82607 1,901 1,792 $22K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 246 217 $22K
84436 2,382 2,205 $13K
83721 1,935 1,892 $13K
84439 1,819 1,697 $12K
36415 Collection of venous blood by venipuncture 8,420 7,691 $11K
86803 875 791 $10K
84153 735 701 $10K
82570 2,429 2,266 $10K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 320 272 $9K
82746 928 903 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 317 272 $9K
86704 632 592 $8K
82728 780 744 $7K
84479 1,337 1,247 $7K
86038 702 664 $7K
80074 211 189 $6K
87340 677 609 $6K
81001 2,753 2,560 $6K
86708 644 605 $6K
80048 Basic metabolic panel (calcium, ionized) 809 762 $6K
86317 555 516 $5K
85027 1,010 939 $5K
86696 375 313 $5K
86141 447 439 $5K
86705 405 371 $5K
82043 1,203 1,141 $4K
83550 767 730 $4K
83970 162 154 $4K
83540 949 908 $4K
84480 511 454 $4K
85045 1,209 1,132 $4K
86592 1,018 930 $4K
86695 375 313 $3K
84481 408 378 $3K
84550 1,000 947 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 113 98 $3K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 222 187 $3K
86431 580 551 $3K
86709 411 379 $2K
83735 522 494 $2K
87086 Culture, bacterial; quantitative colony count, urine 304 267 $2K
85652 962 893 $2K
83690 383 368 $2K
84146 98 89 $1K
82150 372 356 $1K
87088 218 193 $1K
85610 448 364 $1K
80069 131 122 $896.19
82248 231 224 $866.87
86140 231 202 $832.83
83516 60 58 $716.40
86800 74 59 $700.34
87070 115 107 $649.43
86376 62 51 $596.29
82378 34 33 $580.32
85018 231 214 $490.20
87186 75 62 $474.10
87071 65 65 $457.28
84100 148 144 $338.13
84156 207 201 $324.82
84403 13 12 $313.68
86762 30 25 $303.33
82950 70 67 $300.56
83001 16 16 $287.83
80164 28 27 $267.92
85730 105 105 $257.76
81003 190 180 $222.38
84702 17 17 $211.18
80178 24 24 $142.00
86706 16 16 $137.32
82550 17 17 $86.96
81025 15 14 $45.13